Impact of residual moisture and formulation on Factor VIII and Factor V recovery in lyophilized plasma reference materials

被引:0
|
作者
Anthony Hubbard
Sally Bevan
Paul Matejtschuk
机构
[1] National Institute for Biological Standards and Control,
来源
关键词
Lyophilization; Human plasma; Factor VIII; Factor V; Stability;
D O I
暂无
中图分类号
学科分类号
摘要
Residual moisture content and formulation are important parameters when preparing lyophilized reference materials containing labile proteins. The protection of Factor VIII and Factor V activities were monitored in a lyophilized plasma preparation following formulation with either no additional excipient, 40 mM Hepes (4-(2-hydroxyethyl)piperazine-1-ethanesulfonic acid), 10 mg/mL glycine or a combination of 40 mM Hepes and 10 mg/mL glycine. The preservation of Factor VIII activity during freeze-drying was improved by the addition of either stabiliser and improved most, amongst the options studied, by the addition of both glycine and Hepes. The predicted stability at −20 °C and 20 °C was estimated using accelerated degradation studies. Although for plasma lyophilized alone there was some benefit from further desiccation over phosphorus pentoxide, resulting in very low moistures, for suitably formulated samples the predicted stability was as good for freeze-dried only samples as for those with further desiccation. This study emphasises the importance of optimum formulation on the stability of lyophilized proteins.
引用
收藏
页码:2503 / 2507
页数:4
相关论文
共 50 条
  • [41] Safety and efficacy of a long-acting liposomal formulation of plasma-derived factor VIII in haemophilia A patients
    Spira, Jack
    Plyushch, Olga
    Andreeva, Tatiana
    Zorenko, Vladimir
    Zozulya, Nadezhda
    Velichkoi, Irena
    Zalepukhina, Olga Ervinovna
    Yatuv, Rivka
    Baru, Moshe
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2012, 158 (01) : 149 - 152
  • [42] Factor V and VIII Deficiency Treated with Therapeutic Plasma Exchange Prior to Redo Mitral Valve Replacement
    Brown, Laura
    Tilzer, Lowell
    Plapp, Fred
    [J]. JOURNAL OF CLINICAL APHERESIS, 2017, 32 (03) : 196 - 199
  • [43] INSITU-GENERATED THROMBIN IS THE ONLY ENZYME THAT EFFECTIVELY ACTIVATES FACTOR-VIII AND FACTOR-V IN THROMBOPLASTIN-ACTIVATED PLASMA
    PIETERS, J
    LINDHOUT, T
    HEMKER, HC
    [J]. BLOOD, 1989, 74 (03) : 1021 - 1024
  • [44] Factor VIII and fibrinogen recovery in plasma after Theraflex methylene blue-treatment: effect of plasma source and treatment time
    Rapaille, Andre
    Reichenberg, Stefan
    Najdovski, Tome
    Cellier, Nicolas
    de Valensart, Nicolas
    Deneys, Veronique
    [J]. BLOOD TRANSFUSION, 2014, 12 (02) : 226 - 231
  • [45] NORMAL TITER OF FUNCTIONAL AND IMMUNOREACTIVE PROTEIN-C INHIBITOR IN PLASMA OF PATIENTS WITH CONGENITAL COMBINED DEFICIENCY OF FACTOR-V AND FACTOR-VIII
    SUZUKI, K
    NISHIOKA, J
    HASHIMOTO, S
    KAMIYA, T
    SAITO, H
    [J]. BLOOD, 1983, 62 (06) : 1266 - 1270
  • [46] Peri-interventional control of hemostasis with recombinant activated factor VII in a patient with combined coagulation factor V- and factor VIII-deficiency and anaphylaxis to fresh frozen plasma
    Lechner, D.
    Kotz, R.
    Wanivenhaus, H. A.
    Kyrle, P. A.
    Eichinger, S.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 1166 - 1166
  • [47] Peri-interventional control of haemostasis in a patient with combined coagulation factor V- and factor VIII-deficiency and anaphylaxis to fresh frozen plasma - a rare indication for recombinant factor VIIa
    Lechner, D.
    Eichinger, S.
    Wanivenhaus, A.
    Kyrle, P. A.
    [J]. HAEMOPHILIA, 2010, 16 (04) : 705 - 705
  • [48] MEASUREMENT OF APC RESPONSE IN FACTOR-V+VIII DEPLETED PLASMA - IMPROVED SENSITIVITY AND SPECIFICITY OVER CONVENTIONAL ASSAYS
    MAZZOLA, G
    DANGELO, SV
    BERNARDI, F
    PALARETI, G
    SIMIONI, P
    DANGELO, A
    [J]. THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1364 - 1364
  • [49] PLASMA FACTOR-VIII, VARIABLES AFFECTING STABILITY UNDER STANDARD BLOOD-BANK CONDITIONS AND CORRELATION WITH RECOVERY IN CONCENTRATES
    PEPPER, MD
    LEAROYD, PA
    RAJAH, SM
    [J]. TRANSFUSION, 1978, 18 (06) : 756 - 760
  • [50] COAGULATION ABNORMALITIES FOLLOWING INTENSIVE PLASMA-EXCHANGE ON THE CELL SEPARATOR .2. EFFECTS ON FACTOR-I, FACTOR-II, FACTOR-V, FACTOR-VII, FACTOR-VIII, FACTOR-IX, FACTOR-X AND ANTI-THROMBIN-III
    CHIRNSIDE, A
    URBANIAK, SJ
    PROWSE, CV
    KELLER, AJ
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1981, 48 (04) : 627 - 634